NCT02767128View on ClinicalTrials.gov

Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Iron-refractory, Iron-deficiency Anemia (IRIDA)
Interventions
DRUG

Triferic

DRUG

Fer-In-Sol

DRUG

Shohl's solution

Trial Locations (1)

49071

Jasper Clinic, Kalamazoo

All Listed Sponsors
lead

Rockwell Medical Technologies, Inc.

INDUSTRY

NCT02767128 - Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers | Biotech Hunter | Biotech Hunter